miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1

被引:6
作者
Li, Kui [1 ]
Zhou, Zheng [2 ]
Li, Ju [3 ]
Xiang, Rui [4 ]
机构
[1] Guangyuan Cent Hosp, Dept Stomatol, Guangyuan, Sichuan, Peoples R China
[2] Xiangyang Stomatol Hosp, Dept Stomatol, Xiangyang, Hubei, Peoples R China
[3] Chengdu Med Coll, Affiliated Hosp 1, Dept Stomatol, Chengdu, Sichuan, Peoples R China
[4] WuXi Stomatol Hosp, Dept Prosthodont, 6 Jiankang Rd, Wuxi 214000, Jiangsu, Peoples R China
关键词
OSCC; qRT-PCR; MTT; HBP1; miR-146b;
D O I
10.1177/1533033820959404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral squamous cell carcinoma (OSCC) represents more than 90% of all oral cancer and is the most common oral threat around the world. In this study, we examined the roles of miR-146b in OSCC cells. The miR-146b expression in OSCC tissues and cell lines was evaluated by quantitative real-time PCR (qRT-PCR). MTT assay was used to investigate the impact of miR-146b on the growth of OSCC cells in vitro. Transwell assay was utilized to analyze the effect of miR-146b on the migration and invasion of OSCC cells. Target prediction and luciferase assay were employed to demonstrate the interaction between miR-146b and HMG-Box Transcription Factor 1 (HBP1). Western blot was carried out to investigate the protein expressions of HBP1 related genes. miR-146b expression was significantly higher in OSCC tissues and cells compared with paired normal tissues and normal oral keratinocyte cells. Inhibition of miR-146b decreased cell proliferation, migration, and invasion of OSCC cells. Further studies found that HBP1 was a direct target of miR-146b. Co-inhibition of HBP1 reversed the suppressive impact of miR-146b inhibition on OSCC cell proliferation, migration, and invasion. In conclusion-ourresults reveal that miR-146b potentially regulates the proliferation, migration, and invasion of OSCC cells through binding and downregulating HBP1 expression in OSCC cells.
引用
收藏
页数:10
相关论文
共 36 条
[1]   Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma [J].
Ahn, Hyein ;
Yang, Jeong Mi ;
Kim, Hyojin ;
Chung, Jin-Haeng ;
Ahn, Soon-Hyun ;
Jeong, Woo-Jin ;
Paik, Jin Ho .
ONCOTARGET, 2017, 8 (39) :66178-66194
[2]  
Amjadi G., 2019, Thrita, V8, pe100004, DOI [10.5812/thrita.100004, DOI 10.5812/THRITA.100004]
[3]   Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation [J].
Burger, Megan L. ;
Xue, Ling ;
Sun, Yuefang ;
Kang, Chulho ;
Winoto, Astar .
BLOOD, 2014, 123 (26) :4089-4100
[4]   miR-184 promotes cell proliferation in tongue squamous cell carcinoma by targeting SOX7 [J].
Chen, Daiyun ;
Li, Junfu ;
Li, Shunrong ;
Han, Ping ;
Li, Ning ;
Wang, Yi ;
Du, Shouqin .
ONCOLOGY LETTERS, 2018, 16 (02) :2221-2228
[5]   miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAFV600E Mutation [J].
Chou, Chen-Kai ;
Chen, Rong-Fu ;
Chou, Fong-Fu ;
Chang, Hsueh-Wen ;
Chen, Yi-Ju ;
Lee, Ya-Fang ;
Yang, Kuender D. ;
Cheng, Jiin-Tsuey ;
Huang, Chao-Cheng ;
Liu, Rue-Tsuan .
THYROID, 2010, 20 (05) :489-494
[6]   MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia [J].
Correia, Nadia C. ;
Fragoso, Rita ;
Carvalho, Tania ;
Enguita, Francisco J. ;
Barata, Joao T. .
SCIENTIFIC REPORTS, 2016, 6
[7]   Emerging role of microRNA-21 in cancer [J].
Feng, Yin-Hsun ;
Tsao, Chao-Jung .
BIOMEDICAL REPORTS, 2016, 5 (04) :395-402
[8]   MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway [J].
Gao, Song ;
Zhao, Zhiying ;
Wu, Rong ;
Wu, Lina ;
Tian, Xin ;
Zhang, Zhenyong .
AGING-US, 2018, 10 (08) :2113-2121
[9]   Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers [J].
Garcia, Amandine I. ;
Buisson, Monique ;
Bertrand, Pascale ;
Rimokh, Ruth ;
Rouleau, Etienne ;
Lopez, Bernard S. ;
Lidereau, Rosette ;
Mikaelian, Ivan ;
Mazoyer, Sylvie .
EMBO MOLECULAR MEDICINE, 2011, 3 (05) :279-290
[10]   miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance [J].
Javanmardi, Sanaz ;
Aghamaali, Mahmoud Reza ;
Abolmaali, Samira Sadat ;
Mohammadi, Samaneh ;
Tamaddon, Ali Mohammad .
CURRENT GENE THERAPY, 2016, 16 (06) :375-389